Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kyunghyun Yoo"'
Publikováno v:
Molecules, Vol 26, Iss 14, p 4165 (2021)
KRIBB11, an HSF1 inhibitor, was shown to sensitize various types of cancer cells to treatment with several anticancer drugs. However, the exclusive effects of KRIBB11 in preventing the growth of glioblastoma cells and the related mechanisms have not
Externí odkaz:
https://doaj.org/article/c4a817accc7946d4a4c2435b99a78612
Publikováno v:
Cells, Vol 9, Iss 10, p 2325 (2020)
BCL-2 interacting cell death suppressor (BIS), also known as BAG3, is a multifunctional protein. Aberrant expression and mutation of BIS have been implicated in cancers and myopathy. However, there have only been a few studies on the splicing of BIS
Externí odkaz:
https://doaj.org/article/23c411fe31644cf9b56fac828597b1ae
Publikováno v:
Transactions of the Korean Society of Mechanical Engineers - A. 46:329-339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4143fb51397ca558abebdb4734bd1a7
https://doi.org/10.3795/ksme-a.2022.46.4.329
https://doi.org/10.3795/ksme-a.2022.46.4.329
Autor:
Soon-Young Jung, Hye Hyeon Yun, Ji Hee Lim, Dong-Hyung Lee, Sung Bin Seo, Ji-Ye Baek, Jeehan Lee, Kyunghyun Yoo, Hyungmin Kim, Hong Lim Kim, Jeong-Hwa Lee
Publikováno v:
Biochemical and biophysical research communications. 619
Bcl-2-interacting cell death suppressor (BIS), also called as BAG3, regulates numerous physiological processes, such as apoptosis, protein quality control, and senescence. Whole-body Bis-knockout (KO) mice exhibit early lethality following cardiac an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64546da7fd47c61763932e339ab06dc
https://pubmed.ncbi.nlm.nih.gov/35732079
https://pubmed.ncbi.nlm.nih.gov/35732079
Autor:
Mun-Yong Lee, Tae-Ryong Riew, Kyunghyun Yoo, Sung Bin Seo, Hong Lim Kim, Soojin Kim, Jeong-Hwa Lee, Xuyan Jin
Publikováno v:
Molecular Neurobiology. 57:3846-3859
B cell leukemia/lymphoma-2 (Bcl-2)-interacting death suppressor (BIS), also identified as Bcl-2-associated athanogene 3 (BAG3), has been reported to be upregulated in reactive astrocytes after brain insults. The present study was designed to further
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11003082676ee3476a8597d12aedaa9
https://doi.org/10.1007/s12035-020-02000-6
https://doi.org/10.1007/s12035-020-02000-6
Publikováno v:
Molecules
Volume 26
Issue 14
Molecules, Vol 26, Iss 4165, p 4165 (2021)
Volume 26
Issue 14
Molecules, Vol 26, Iss 4165, p 4165 (2021)
KRIBB11, an HSF1 inhibitor, was shown to sensitize various types of cancer cells to treatment with several anticancer drugs. However, the exclusive effects of KRIBB11 in preventing the growth of glioblastoma cells and the related mechanisms have not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e9a39bfba91d847bfcf43bf99e6dd1
http://europepmc.org/articles/PMC8305965
http://europepmc.org/articles/PMC8305965
Autor:
Hye Hyeon, Yun, Soon Young, Jung, Bong Woo, Park, Ji Seung, Ko, Kyunghyun, Yoo, Jiyoung, Yeo, Hong Lim, Kim, Hun Jun, Park, Ho Joong, Youn, Jeong Hwa, Lee
Publikováno v:
International Journal of Molecular Sciences
BCL-2 interacting cell death suppressor (BIS) is a multifunctional protein that has been implicated in cancer and myopathy. Various mutations of the BIS gene have been identified as causative of cardiac dysfunction in some dilated cardiomyopathy (DCM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b47fb2c72bdc48e673c6a08adac98932
https://pubmed.ncbi.nlm.nih.gov/33572816
https://pubmed.ncbi.nlm.nih.gov/33572816
Publikováno v:
Cells, Vol 9, Iss 2325, p 2325 (2020)
Cells
Volume 9
Issue 10
Cells
Volume 9
Issue 10
BCL-2 interacting cell death suppressor (BIS), also known as BAG3, is a multifunctional protein. Aberrant expression and mutation of BIS have been implicated in cancers and myopathy. However, there have only been a few studies on the splicing of BIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9790837ff1686e930b072314b2c9b3
https://www.mdpi.com/2073-4409/9/10/2325
https://www.mdpi.com/2073-4409/9/10/2325